Carter calls for report on PBMs’ impact on rising drug costs
WASHINGTON, D.C. – In a letter to Federal Trade Commission (FTC) Chair Lina M. Khan, Rep. Earl L. “Buddy” Carter (R-GA) called for an investigation into Pharmacy Benefit Manager’s (PBMs) predatory practices, which lead to higher prices on prescriptio....
Read More